FINAL Program
The scientific program was organized to last approximately three hours each day of the event. Below is the final program. Hyperlinks will take you to presentation videos hosted by the SRS YouTube account.
22 September - Section / Speaker
SRS and the New Initiative to Support Radiopharmaceutical Research, Training, and Education in Latin America
Prof. Antony Gee, Dr. Neydher Berronterán-Infante, Dr. Fabio L. N. Marques
Scientific Section 1: Radiopharmaceutical Design and Evaluation
GT06- In Silico Evaluation of New 18F Pet Radiodrugs, Analogs of Mangiferin
(Andy Rodríguez – CU)
PC04- A Database of Voxel-Based Small Animal Models for Internal Dosimetry: Improving Dose Evaluation in Preclinical Trials
(Bruno Mendes - BR)
GE02- Design, Synthesis, and Evaluation of a Family of 99mTc Estradiol Derivatives for Breast Cancer Imaging
(María Tejería – UY)
GE07- Development and Evaluation of a Series of 99mTc-Complexes for Androgen Receptor Imaging
(María Cardoso – UY)
Keynote 1: Radiotracer Design
Dr. Oscar Leonel Ruiz Ramirez (MX)
Section 2 - Oncology: Diagnostic and Related Issues
PC09- Physicochemical and Biological Evaluation of a Radiolabelled Antimicrobial Peptide as Potential Agent
for Diagnostic of Infections
(Jessica Osorio – UY)
PC11- Comparative Studies of the Physical and Biological Properties of Peptides Labeled With 1131I and 99mTc(CO)3-.
Relevance to Glioblastoma
(Danielle Sobral – BR)
PC05- Evaluation of MCP Anticancer Activity Using Molecular Imaging
(Fábio da Silva – BR)
Keynote 2: Radiotracer Evaluation in the Pre-clinical Stage
Prof.Daniele de P. Faria (BR)
23 September - Section / Speaker
Keynote 3: Latin American Radiopharmacy: Status and Perspectives
Prof. Miguel Avila-Rodriguez (MX)
Section 3 - Oncology: Therapy and Related Issues
GE03 - Unexpected Problems During Automated One-Pot Labeling of High Specific Activity 131i-Mibg for Therapy
(Gustavo Messina, AR)
GT05 - In Situ Intake Surveillance of Nuclear Medicine Worker Using a Thyroid Probe: Two Years Experience
(Adlin Díaz – CU)
PC08 - Functionalized Auger Emitting AU-198 Doped Nanoparticles as a Therapeutic Strategy for the Treatment of Cancer Metastases
(Gamal Akabani – USA)
PC07 - Development of 177lu-Dn(c19)-cxcr4 Ligand Nanosystem for Combinatorial Therapy in Pancreatic Cancer
(Pedro Cruz-Nova – MX)
Keynote 4: Challenges In The Production of Radiometal in Cyclotron
Dr. Juan C. Manrique-Arias (MX)
Section 4 - Cyclotron and reactor process
CR01 - Production of 89zr and 64cu for Use in Molecular Imaging Studies
(Heber Videira – BR)
CR02 - Preliminary Settings of a Liquid 68ga Target and Post Purification System Tunings
(Sebastián Fila – AR)
CR03 – Hydrogen Production by Urea Electrolysis and Application in Nuclear Medicine: A Sustainable and Modern Way of Production
(Eduardo Ocampo – MX)
CR04 - Preliminary Irradiation Tests and Calculations to Obtain 32p From a (n,γ) Reaction at Ra-6 for Sirt Treatments of Hepatocellular Carcinoma With Microspheres
(Soldati Analía – AR)
Keynote 5: Molecular Target For Theranostics in Oncology
Prof. Frederik Giesel (DE)
24 SEPTEMBER - SECTION / SPEAKER
Keynote 6: IAEA – Supporting the development of radiopharmacy in Latin America
Prof. João A. Osso (IAEA)
Section 5 - Neurology: Diagnostic and related issues
CFNO02 - Optimization of Analytical Methodology for Determining the Metabolization of 11 C-pk11195
(Gabrielle Carvalho – BR)
CFNO05 - 18f- Labeled Kenpaulone, Potential Radioligandfor Alzheimer’s Disease
(Maia Zeni – UY)
PC06 - In Vitro Uptake Evaluation of a 18f-Labeled Sulforhodamine 101 in CNS Cells
(Rosina Dapueto – UY)
Keynote 7: 11C Radiotracers Preparation Besides Methylation
Dr. Pablo J. Buccino Evans (USA/UY)
Round Table: The Importance of the Basic Research in Radiopharmaceutical Sciences and How to Promote it in Latin America
Dra. Blanca Ocampo (MX), Dr. Adriano Duatti (IT), Dra Marina Bicalho Silveira (BR), Dr. Guillermo Casale (AR)
Keynote 8: Radiopharmaceuticals Supporting Neurological Drugs Development
Prof. Pedro Rosa Neto (CA/BR)
Final Words and Wrap-Up and Next Steps
Antony Gee and Fabio L. N. Marques